Singh J, Carlisle D L, Pritchard D E, Patierno S R
Department of Pharmacology, The George Washington University Medical Center, Washington, DC 20037, USA.
Oncol Rep. 1998 Nov-Dec;5(6):1307-18. doi: 10.3892/or.5.6.1307.
The adverse health effects linked with chromium (Cr) exposure, the role of solubility and chemical speciation of Cr compounds, and the diverse cellular and molecular effects of Cr make the study of Cr carcinogenesis and toxicology very interesting and complex. Certain Cr compounds are prominent metal carcinogens in both occupational and environmental settings. Inhaled particulate forms of hexavalent Cr [Cr(VI)] cause lung cancer as well as lung toxicity. Some of the important factors in determining the biological outcome of Cr exposure include the bioavailability, chemical speciation and solubility of Cr compounds, intracellular reduction, and interaction of Cr with DNA. The stable oxidation states of Cr found in nature are Cr(III) and Cr(VI). Cr(III) is unable to enter cells but Cr(VI) enters into cells through membrane anionic transporters. Intracellular Cr(VI) is metabolically reduced to the ultimate Cr(III). Cr(VI) does not react with macromolecules such as DNA, RNA, proteins and lipids. However, both Cr(III) and the reductional intermediate Cr(V) are capable of co-ordinate covalent interactions with macromolecules. At the genomic level, Cr genotoxicity manifests as gene mutations, several types of DNA lesions and inhibition of macromolecular synthesis. At the cellular level, Cr exposure may lead to cell cycle arrest, apoptosis, premature terminal growth arrest, or neoplastic transformation. Cr-induced DNA-DNA interstrand crosslinks (DDC), the tumor suppressor gene p53 and oxidative processes are some of the major factors that may play a significant role in determining the cellular outcome in response to Cr exposure. We have utilized cellular, molecular, pharmacological, and genetic approaches to understand the interrelationship between Cr-induced genotoxicity, apoptosis and carcinogenesis. This review is based on the results and inferences of this research. We hope this review will clarify existing concepts and also introduce novel perspectives in chromium carcinogenesis research.
与铬(Cr)暴露相关的不良健康影响、Cr化合物的溶解度和化学形态的作用,以及Cr的多种细胞和分子效应,使得Cr致癌作用和毒理学的研究既非常有趣又复杂。某些Cr化合物在职业和环境环境中都是重要的金属致癌物。吸入的六价Cr [Cr(VI)]颗粒形式会导致肺癌以及肺部毒性。决定Cr暴露生物学结果的一些重要因素包括Cr化合物的生物利用度、化学形态和溶解度、细胞内还原以及Cr与DNA的相互作用。自然界中发现的Cr的稳定氧化态是Cr(III)和Cr(VI)。Cr(III)无法进入细胞,但Cr(VI)通过膜阴离子转运体进入细胞。细胞内的Cr(VI)通过代谢还原为最终的Cr(III)。Cr(VI)不与DNA、RNA、蛋白质和脂质等大分子反应。然而,Cr(III)和还原中间体Cr(V)都能够与大分子进行配位共价相互作用。在基因组水平上,Cr的遗传毒性表现为基因突变、几种类型的DNA损伤和大分子合成的抑制。在细胞水平上,Cr暴露可能导致细胞周期停滞、凋亡、过早的终末生长停滞或肿瘤转化。Cr诱导的DNA - DNA链间交联(DDC)、肿瘤抑制基因p53和氧化过程是可能在决定Cr暴露的细胞结果中起重要作用的一些主要因素。我们利用细胞、分子、药理学和遗传学方法来理解Cr诱导的遗传毒性、凋亡和致癌作用之间的相互关系。本综述基于这项研究的结果和推论。我们希望本综述将阐明现有概念,并在铬致癌研究中引入新的观点。